A PHASE 3, MULTI-CENTER, MULTINATIONAL, RANDOMIZED, DOUB

Project: Research project

Project Details

Description

A PHASE 3, MULTI-CENTER, MULTINATIONAL, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MP-376 (LEVOFLOXACIN INHALATION SOLUTION; AEROQUIN) IN STABLE CYSTIC FIBROSIS PATIENTS
StatusFinished
Effective start/end date2/10/1112/31/12

Funding

  • MPEX PHARMACEUTICALS, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.